Vasquez Christian 4

What Happened Christian Vasquez, Chief Financial Officer of BioAtla, was granted an award of 240,000 restricted stock units (RSUs) on March 10, 2026. The Form 4 reports the acquisition at $0.00 per share (typical for RSU grants); the filing does not state a cash payment. This is an equity award (not an open-market purchase or sale), so it reflects compensation rather than an immediate buy/sell signal.

Key Details

• Transaction date: 2026-03-10; Form 4 filed: 2026-03-12 (timely filing).
• Amount: 240,000 RSUs acquired at $0.00 per share (no immediate cash outlay).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote (vesting): 25% of the RSUs vest on March 10, 2027; thereafter 6.25% of the total shares vest on the last day of each May, August, November and February, subject to continued service.
• No 10b5-1 plan, tax-withholding sale, or other special codes indicated in the provided details.

Context RSUs are time-based equity awards that convert into company shares only as they vest; they do not represent an immediate market purchase and do not necessarily indicate personal buying or selling intent. The economic value will depend on BioAtla’s stock price at each vesting date.